|  | bid: | $2,00 | | ask: | $2,50 | | (RTS Stock Exchange, 11am, 22.12.08) |
History and achievementsBusiness Growth and Diversification. National ExpansionAdditional issue of Pharmacy Chain 36.6 ordinary shares; 1.5 million ordinary shares placed on the MICEX Veropharm IPO on the MICEX Placement of 3 billion ruble bond issue through public subscription on the MICEX Launch of the first Early Learning Center (ELC) store in Moscow Acquisition of the European Medical Center (EMC) group of companies Launch of 36.6 private label products sales Pharmacy Chain 36.6 becomes the exclusive representative of Boots in Russia Development of an in-house logistics system and switch to a new IT platform Pharmacy Chain 36.6 becomes the first Russian company to join the National Retail Federation (NRF) S&P includes 36.6 on a ranking of 50 publicly traded Russian companies by transparency
RestructuringCompany restructuring and the formation of Pharmacy Chain 36.6 Pharmacy Chain 36.6 IPO on the MICEX First branded pharmacy outside Moscow 61 branded pharmacies at the end of 2003
Strategy DevelopmentRetail strategy and business concept development in collaboration with McKinsey & Co. First 36.6 pharmacy opens in Moscow 28 branded pharmacies at the end of 2001 Veropharm founded in 1997; majority stake in LENS-Pharm, the largest domestic manufacturer of oncological products, purchased in 2001
Company Foundation- Foundation of pharmaceutical business by Artem Bektemirov and Sergey Krivosheev
- Expansion of distribution network to wholesale operations in 12 regions and retail sales in Moscow, Murmansk and other cities
- Acquisition of pharmaceutical plants in Belgorod and Voronezh
|
